Mardia Samyoung Capillary Tubes Company Ltd (MSCTC) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Mardia Samyoung Capillary Tubes Company Ltd on NSE and BSE, with an AI summary of each filing.
Result for the Quarter ended on 30th September, 2026
Financial Result · 27 Oct 2026, 3:09 am
Mardia Samyoung Capillary Tubes Reports Q2 FY27 Financial Results Mardia Samyoung Capillary Tubes reported total revenue from operations of ₹2,337.62 lakhs for the quarter ended 30th Sep'26, up sharply YoY from ₹40.88 lakhs in 30th Sep'25, though marginally lower QoQ from ₹2,483.91 lakhs in 30th Jun'26. Net profit stood at ₹97.86 lakhs versus ₹1.72 lakhs YoY and ₹105.06 lakhs QoQ, with EPS at ₹0.12. For H1 ended 30th Sep'26, revenue reached ₹4,821.53 lakhs with net profit of ₹202.92 lakhs. Statutory auditors issued an emphasis of matter regarding unconfirmed trade balances and borrowings.
Outcome of the Board Meeting held on today i.e. 26th October, 2026
Outcome · 27 Oct 2026, 3:04 am
Mardia Samyoung Capillary Tubes Company Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,338 (+5618.2% YoY | -5.9% QoQ) ■ EBITDA: 129 (+7428.5% YoY | -8.8% QoQ) ■ EBITDA Margin (%): 5.5 (+133 bps YoY | -18 bps QoQ) ■ PAT: 97.9 (+5589.5% YoY | -6.9% QoQ) ■ EPS (INR): 0.12 (+500.0% YoY | -7.7% QoQ)
Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation ....
Intimation · 26 Oct 2026, 5:30 am
Mardia Samyoung Capillary Tubes Schedules Board Meeting for Q2 Earnings Mardia Samyoung Capillary Tubes Company Limited has scheduled a meeting of its Board of Directors on 26th Oct'26 at its registered office. The board will convene primarily to consider, approve, and take on record the company's unaudited financial results for the period ended 30th Sep'26, alongside other general business matters.
Submission of Voting Results alongwith Scrutinizer Report for the AGM held on September 29, 2026.
Annual General Meeting · 01 Oct 2026, 11:12 pm
Outcome of the 34th Annual General Meeting of the Company held on today i.e. 29th September, 2026
Annual General Meeting · 29 Sept 2026, 10:23 pm
Annual Report for the financial year ended March 31, 2026.
Others (Uncategorized) · 05 Sept 2026, 4:12 am
Annual Report including copy of Notice of AGM to be held on September 29, 2026.
Annual General Meeting · 05 Sept 2026, 3:59 am
Outcome of the Board Meeting held today i.e. 03rd September, 2026
Outcome · 03 Sept 2026, 6:11 pm
Mardia Samyoung Approves Auditor Appointments and Office Relocation to Gujarat On 3rd Sep'26, Mardia Samyoung's Board scheduled its 34th AGM for 29th Sep'26 and approved shifting its registered office from Maharashtra to Gujarat, subject to shareholder approval. The Board also appointed M/s S K Bhavsar & Co. as Statutory Auditors and M/s Shekhawat & Associates as Secretarial Auditors. Both auditor appointments are for five-year terms spanning FY27 through FY31. The office relocation will prompt corresponding updates to the company's Memorandum of Association.
Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 ,inter alia, to consider and approve Intimation ....
Intimation · 27 Aug 2026, 9:51 pm
Mardia Samyoung Board to Consider Shifting Registered Office to Gujarat Mardia Samyoung Capillary Tubes' Board of Directors will meet on 03 Sep'26 to consider several key items. The main agenda includes approving a proposal to shift the company's registered office from the state of Maharashtra to Gujarat, subject to member approval. The Board will also approve the date and agenda for the upcoming Annual General Meeting (AGM) and the Directors' Report for the Financial Year 2025-26. This potential relocation is a significant corporate development for the company.
Intimation regarding Functional website of the Company pursuant to Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 19 Aug 2026, 5:21 pm
Mardia Samyoung Launches New Website Post-Acquisition Mardia Samyoung Capillary Tubes Company Ltd (Scrip: 513544) announced on Aug 19, '26, the launch of its new functional website, www.mardiasygltd.com. This development follows the company's acquisition as a going concern through a liquidation process. The website was created to comply with SEBI's Regulation 46 for information dissemination. The company noted it is currently in the process of updating the site with all requisite disclosures and will ensure timely updates moving forward.
Unaudited Financial Result for the Quarter ended on 30th June, 2026
Financial Result · 12 Aug 2026, 3:40 am
Mardia Samyoung Q1FY27 Results Weaken QoQ; Auditor Flags Concerns Mardia Samyoung reported a net profit of ₹105.06 lakhs for the quarter ended 30 Jun'26, down 8.4% QoQ from ₹114.72 lakhs. Revenue from operations fell 59.4% QoQ to ₹2483.91 lakhs. Basic EPS stood at ₹0.13, a decrease from ₹0.17 in the prior quarter. The auditor's limited review report highlighted an "Emphasis of Matter," noting an inability to verify the end-use of ₹15.82 crores raised from warrant conversion, inventory valuation, trade balances, and the recoverability of ₹22.84 crores in interest-free advances.
Outcome of the Board Meeting held today i.e. 11th August, 2026 for the Unaudited Financial Result for the Quarter ended on 30.06.2026.
Outcome · 12 Aug 2026, 3:31 am
Mardia Samyoung Capillary Tubes Company Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 2,484 (-59.4% QoQ) ■ EBITDA: 142 (Loss to Profit YoY | -21.3% QoQ) ■ EBITDA Margin (%): 5.7 (+276 bps QoQ) ■ PAT: 105 (Loss to Profit YoY | -8.4% QoQ) ■ EPS (INR): 0.13 (Loss to Profit YoY | -23.5% QoQ)
Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Intimation ....
Intimation · 11 Aug 2026, 5:30 am
Mardia Samyoung Capillary Tubes Board Meeting Set for Aug'26 to Approve Q1 Results Mardia Samyoung Capillary Tubes (BSE: 513544) has scheduled a Board of Directors meeting for 11th Aug'26. The primary agenda is to consider and approve the unaudited financial results for the quarter ended 30th Jun'26. The meeting will take place at the company's registered office.
Intimation regarding change of Corporate Identification Number (CIN) of the Company.
Others (Uncategorized) · 25 May 2026, 6:39 pm
Mardia Samyoung Announces Corporate Identification Number (CIN) Change Mardia Samyoung Capillary Tubes Company Ltd. (Scrip: 513544) announced on 25 May'26 that its Corporate Identification Number (CIN) has been revised. The new CIN, as updated in the records of the Ministry of Corporate Affairs, is L20132MH1992PLC069104. The company has requested the BSE to update its records accordingly. This change is a procedural update and does not reflect any change in the company's capital structure or business operations.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 13 May 2026, 12:35 am
Mardia Samyoung Confirms Non-Applicability of Large Corporate Framework Mardia Samyoung Capillary Tubes Company Ltd (Scrip: 513544) informed the BSE on 12 May'26 that it does not fall under the SEBI 'Large Corporate' criteria as of 31 Mar'26. This classification exempts the company from the mandatory requirement to raise a portion of its incremental borrowings via debt securities. The filing confirms the company had ₹0.00 Cr in outstanding borrowings and no credit rating, thus not meeting the framework's applicability thresholds.
Statement of Deviation & Variation for the period ended March 31, 2026.
Others (Uncategorized) · 13 May 2026, 12:24 am
Mardia Reports No Deviation in Use of Preferential Issue Proceeds Mardia Samyoung Capillary Tubes confirms no deviation in the utilization of funds raised via preferential issues for the quarter ended 31 Mar'26. The funds, raised in multiple tranches during Feb'26 for working capital requirements, have been utilized as per the stated objectives. The company's statement of deviation and variation, filed on 12 May'26, shows nil variation, with no changes to the objects of the issue. This update covers all preferential allotments made between 04 Feb'26 and 16 Feb'26.
Financial Results for the period ended March 31, 2026.
Financial Result · 13 May 2026, 12:13 am
MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 6112 (+395.1% QoQ) ■ EBITDA: 181 (Loss to Profit YoY | -4.7% QoQ) ■ EBITDA Margin (%): 3.0 (-1239 bps QoQ) ■ PAT: 115 (Loss to Profit YoY | -11.1% QoQ) ■ EPS (INR): 0.17 (Loss to Profit YoY | -90.8% QoQ)
Approval of Audited Financial Results for the period ended March 31, 2026.
Outcome · 13 May 2026, 12:00 am
MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 6112 (+395.1% QoQ) ■ EBITDA: 181 (Loss to Profit YoY | -4.7% QoQ) ■ EBITDA Margin (%): 3.0 (-1239 bps QoQ) ■ PAT: 115 (Loss to Profit YoY | -11.1% QoQ) ■ EPS (INR): 0.17 (Loss to Profit YoY | -90.8% QoQ)
Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve 1. ....
Intimation · 12 May 2026, 5:30 am
Mardia Samyoung Capillary Tubes Board Meeting to Approve FY26 Financial Results Mardia Samyoung Capillary Tubes Company Ltd (BSE: 513544) has scheduled a Board of Directors meeting on 12 May'26. The key agenda item is to consider and approve the company's audited financial results for the period ending 31 Mar'26. This meeting is crucial for investors as the results will provide a comprehensive overview of the company's financial performance for the full fiscal year.
The board of directors approved interalia the following: 1. Appointment of Mr. Ramesh Sharma (DIN: 10728184) as a Non-Executive Independent Director (Additional). 2. Appointment of ....
Change in Management · 06 May 2026, 11:49 pm
Mardia Announces Board and Committee Overhaul Mardia Samyoung Capillary Tubes announced significant board changes effective 06 May'26. The company appointed Mr. Ramesh Sharma and Ms. Geetika Garg as Non-Executive Independent Directors for five-year terms. Concurrently, Ms. Sonalben Vaghela and Mr. Jaykumar Bhaveshkumar Patel resigned from their positions as Non-Executive Independent Directors, citing professional commitments. Following these changes, the board reconstituted its Audit, Nomination & Remuneration, and Stakeholder Relationship committees. Mr. Ramesh Sharma will now chair all three reconstituted committees.
The Board of Directors approved inter-alia the following; 1. Appointment of Mr. Ramesh Sharma (DIN: 10728184) as a Non-Executive Independent Director (Additional). 2. Appointment ....
Others (Uncategorized) · 06 May 2026, 11:40 pm
Mardia Samyoung Announces Board and Committee Overhaul Mardia Samyoung announced significant board changes effective May 06, '26. The company appointed Mr. Ramesh Sharma and Ms. Geetika Garg as new Non-Executive Independent Directors for five-year terms. Concurrently, Ms. Sonalben Vaghela and Mr. Jaykumar Bhaveshkumar Patel resigned from their positions as Non-Executive Independent Directors, citing professional commitments. Following these changes, the board reconstituted its Audit, Nomination & Remuneration, and Stakeholder Relationship Committees, with Mr. Ramesh Sharma appointed as Chairperson for all three.
Allotment Of 39,00,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 39,00,000 Fully Convertible Equity Warrants ("Warrants'''')
Others (Uncategorized) · 14 Apr 2026, 12:00 am
Mardia Samyoung Approves Equity Share Allotment from Warrant Conversion On Apr 13, '26, Mardia Samyoung's board approved allotting 3.9M equity shares (FV ₹10) from the conversion of warrants. The warrants were originally issued on a preferential basis on Feb 06, '26, at ₹13.50 per warrant to a non-promoter entity. This conversion increases the paid-up share capital from ₹75.55cr (75.55M shares) to ₹79.45cr (79.45M shares), resulting in an equity dilution of approximately 4.91%. This action increases the total number of outstanding shares and raises fresh capital for the company.
Allotment Of 78,15,000 Equity Shares Of Face Value Of INR 10/- Each Pursuant To Conversion Of 78,15,000 Fully Convertible Equity Warrants ("Warrants'''')
Others (Uncategorized) · 11 Apr 2026, 10:50 pm
Mardia Allots 78.15 Lakh Equity Shares Following Warrant Conversion On Apr 11, '26, Mardia Samyoung Capillary Tubes' board approved allotting 78,15,000 equity shares (face value INR 10) from the conversion of warrants. The warrants were issued on a preferential basis to two non-promoters on Feb 06, '26, at INR 13.50 per warrant. This action increases the company's paid-up equity share capital from INR 67.73 crore (6.77 crore shares) to INR 75.55 crore (7.55 crore shares), resulting in an equity dilution of approximately 10.3%.
Voting Results alongwith Scrutinizer Report for the Extra-Ordinary General Meeting held on February 20, 2026
Extra Ordinary General Meeting · 20 Feb 2026, 11:19 pm
Mardia Samyoung Shareholders Approve Auditor and Managing Director Appointments At its EGM on 20th Feb'26, Mardia Samyoung shareholders approved two key ordinary resolutions. The first resolution, for the appointment of M/s S K Bhavsar & Co. as Statutory Auditors, passed with nearly 100% of votes in favor. The second resolution, for the appointment and regularization of Mr. Dhaval Dharmendrabhai Joshi as Managing Director, also passed with near-unanimous approval. Promoter group votes were decisive in both outcomes, with 99.29% of promoter shares polled, ensuring requisite majority for both proposals.
Proceedings of Extra-Ordinary General Meeting held on February 20, 2026.
Extra Ordinary General Meeting · 20 Feb 2026, 8:46 pm
Mardia Samyoung EGM Approves Key Appointments Mardia Samyoung Capillary Tubes Company Limited announced the results of its Extra-Ordinary General Meeting held on 20th Feb'26. Shareholders passed ordinary resolutions to approve the appointment of M/s S K Bhavsar & Co. as the company's Statutory Auditors. Additionally, the appointment of Mr. Dhaval Dharmendrabhai Joshi (DIN: 10778731) as Managing Director was regularized. Detailed voting results will be disclosed separately.